期刊文献+

西红花提取物调控免疫细胞,提高程序性死亡受体-1抑制剂治疗肺腺癌效果的实验研究

Experimental study of saffron extracts to modulate immune cells to improve the efficacy of a programmed death-1 inhibitor in the treatment of lung adenocarcinoma
下载PDF
导出
摘要 目的:多项研究提示,西红花提取物能影响肿瘤的发展进程。本实验探究西红花提取物在肺腺癌小鼠模型中对肿瘤免疫微环境和免疫治疗的影响,为西红花提取物抗肿瘤研究提供更多基础性数据。方法:构建Lewis肺癌细胞和萤光素酶稳定结合的小鼠皮下瘤模型,观察西红花提取物对小鼠皮下瘤和肿瘤免疫微环境的影响:运用活体成像技术跟踪肿瘤生长情况;运用流式细胞技术检测小鼠CD4^(+)、CD8^(+)T细胞的数量及占比;运用反转录-聚合酶链式反应技术检测程序性死亡受体配体1、含有T细胞免疫球蛋白和黏蛋白结构域的蛋白3(T cell immunoglobulin and mucin domaincontaining protein 3,TIM3)、淋巴细胞活化基因-3(lymphocyte-activation gene-3,LAG3)、具有免疫球蛋白和ITIM结构域的T细胞免疫受体(T cell immunoreceptor with immunoglobulin and ITIM domain,TIGIT)、胸腺细胞选择相关的高迁移率族蛋白(thymocyte selection-associated high mobility group box,TOX)1、TOX2、TOX3基因的mRNA表达情况。结果:与对照组相比,给予西红花提取物能一定程度地抑制小鼠皮下瘤的生长(P<0.05),且小鼠CD4^(+)、CD8^(+)T细胞的数量及占比均增加(P<0.05),TIM3、LAG3、TIGIT、TOX1、TOX2、TOX3的基因表达均上调(P<0.05)。结论:西红花提取物能提高肺腺癌免疫微环境中的CD4^(+)、CD8^(+)T细胞的占比,增强免疫治疗的抗肿瘤作用,进而提高肺癌免疫治疗效果,抑制肺癌发展。 Objective:A number of studies have shown that saffron extracts can affect the development of tumor.This study explored the effect of saffron extract on tumor immune microenvironment and immunotherapy in a mouse model of lung adenocarcinoma so as to provide more basic data for the anti-tumor research of saffron extracts.Methods:The transplanted tumor model of Lewis lung carcinoma-luciferase in mice was established to detect the effect of saffron extracts on the transplanted tumor in vivo.At the same time,the tumor growth was tracked by in vivo imaging technique.The number and proportion of CD4^(+)and CD8^(+) T cells were determined by flow cytometry.The mRNA levels of programmed death-ligand 1,T cell immunoglobulin and mucin domain-containing protein 3(TIM3),lymphocyte-activation gene-3(LAG3),T cell immunoreceptor with immunoglobulin and ITIM domain(TIGIT),thymocyte selection-associated high mobility group box(TOX)1,TOX2 and TOX3 were detected by reverse transcription-polymerase chain reaction(RT-PCR)and immunohistochemical techniques to verify the effect of saffron extracts on the regulation of tumor immune microenvironment.Results:Compared with the control group,the administration of saffron extracts could inhibit the growth of subcutaneous tumor in mice to a certain extent,and the number and proportion of CD4^(+) and CD8^(+) T cells were increased(P<0.05),and the expression of genes encoding TIM3,LAG3,TIGIT,TOX1,TOX2 and TOX3 was up-regulated(P<0.05).Conclusion:The saffron extracts can increase the proportion of CD4^(+) and CD8^(+) T cells in tumor microenvironment,enhance the anti-tumor effect of immunotherapy,thereby improving the effect of lung cancer immunotherapy and inhibiting the development of lung cancer.
作者 李诗颖 李存雅 张雪 钟薏 LI Shiying;LI Cunya;ZHANG Xue;ZHONG Yi(Department of Oncology,Shanghai TCM-Integrated Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200082,China;Shanghai Traditional Chinese Medicine Co.,Ltd.,Shanghai 200082,China)
出处 《上海医药》 2024年第1期3-11,28,共10页 Shanghai Medical & Pharmaceutical Journal
基金 上海市2022年度“科技创新行动计划”医学创新研究专项项目(22Y31920104) 上海市2022年度“科技创新行动计划”启明星培育(扬帆专项)项目(22YF1444900) 上海市虹口区第二轮“国医强优”三年行动计划(2022—2024年)中西医结合重点专科、薄弱专科建设项目(HKGYQYXM-2022-10) 上海市2021年度“科技创新行动计划”扬帆计划项目(21YF444400) 山东省乡村振兴基金会张秀兰慈善基金项目。
关键词 西红花 免疫微环境 肺腺癌 免疫治疗 saffron immune microenvironment lung adenocarcinoma immunotherapy
  • 相关文献

参考文献4

二级参考文献32

  • 1Fontenot JD, Gavin MA, Rudensky AY. Foxp3 program the development and function of CD4^+ CD25^+ regulatory T cells[ J]. Nat Immunol, 2003,4:330-338.
  • 2Birebent B, Lorho R, Lechartier H, et al. Suppressive properties of human CD4^+ CD25^+ regulatory T cells are dependent on CTLA-4 expression [J]. Eur J Immunol, 2004,34:1 - 12.
  • 3Staveley-O' Carroll K, Sotomayor E, Montgomery J, et al. Induction of antigen-specific T cell anergy : An early event in the course of tumor progression[ J]. PNAS, 1998, 95 : 1178 - 1183.
  • 4Beck C, Schreiber H, Rowley D. Role of TGF-β in immune-evasion of Cancer[J]. Mico Res & Tech, 2001, 52:387-395.
  • 5Rich J, Borton A, Wang X. Transforming growth factor-β signaling in cancer[J]. Mico Res & Tech, 2001, 52:363-373.
  • 6Oaks MK, Hallett KM, Penwell RT, et al. A native soluble form of CTLA-4[J]. Cell Immunol, 2004, 201:144 - 153.
  • 7Oaks MK, Hallett KM. Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease [J].J Immunol , 2000,164:5015-5018.
  • 8Sabatos CA, Chakravarti S, Cha E, et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 response and induction of peripheral tolerance[ J]. Nat Immunol, 2003, 4:1102 - 1110.
  • 9Sanchez-Fueyo A, Tian J, Picarella D, et al. Tim-3 inhibits T helper type 1-mediated auto-and alloimmune responses and promotes immuno-logical tolerance[ J]. Nat Immunol,2003,4:1093 - 1111.
  • 10Monney L, Sabatos CA, Gaglia JL, et al. Th1-specific cell surface protein Tim-3 regulate macrophage activation and severity of an auto-immune disease[J]. Nature, 2002, 415:536 - 541.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部